Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 8:51 pm Purchase |
2024-09-30 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Ikarian Capital LLC | 133,404 3.900% |
133,404 (New Position) |
Filing History |
| 2024-04-05 4:10 pm Sale |
2024-03-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Ikarian Capital LLC | 133,547 5.900% |
-4,730 (-3.42%) |
Filing History |
| 2024-03-19 11:20 am Sale |
2024-01-12 | 13G | TRACON Pharmaceuticals, Inc. TCON |
aaronson wayne | 35,846 2.300% |
-53,076 (-59.69%) |
Filing History |
| 2024-02-14 4:31 pm Sale |
2023-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Lincoln Park Capital Fund LLC | 5,841 0.375% |
-112,650 (-95.07%) |
Filing History |
| 2024-02-09 4:05 pm Sale |
2023-12-31 | 13D | TRACON Pharmaceuticals, Inc. TCON |
Opaleye Management Inc. | 0 0.000% |
-125,919 (Position Closed) |
Filing History |
| 2023-06-02 4:46 pm Purchase |
2023-05-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Lincoln Park Capital Fund LLC | 118,491 8.980% |
118,491 (New Position) |
Filing History |
| 2023-02-14 12:57 pm Purchase |
2022-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Ikarian Capital LLC | 138,277 12.500% |
3,721 (+2.77%) |
Filing History |
| 2023-02-10 2:07 pm Purchase |
2022-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
aaronson wayne | 88,923 8.170% |
15,617 (+21.30%) |
Filing History |
| 2022-04-29 5:17 pm Purchase |
2022-04-12 | 13G | TRACON Pharmaceuticals, Inc. TCON |
aaronson wayne | 73,306 7.000% |
73,306 (New Position) |
Filing History |
| 2022-02-14 4:37 pm Sale |
2021-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Ikarian Capital LLC | 134,556 13.800% |
-1,287 (-0.95%) |
Filing History |
| 2022-01-27 4:03 pm Unchanged |
2021-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Linden Capital L.P. | 46,080 4.600% |
0 (Unchanged) |
Filing History |
| 2021-03-10 9:40 pm Sale |
2020-08-05 | 13D | TRACON Pharmaceuticals, Inc. TCON |
New Enterprise Associates 14, L.P. | 0 0.000% |
-17,844 (Position Closed) |
Filing History |
| 2021-02-16 3:09 pm Sale |
2020-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
683 Capital Management, LLC | 9,945 1.300% |
-3,000 (-23.18%) |
Filing History |
| 2021-02-16 08:33 am Purchase |
2020-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Ikarian Capital LLC | 135,842 17.800% |
27,715 (+25.63%) |
Filing History |
| 2021-02-12 5:20 pm Purchase |
2020-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Opaleye Management Inc. | 125,919 17.040% |
125,919 (New Position) |
Filing History |
| 2021-02-09 3:17 pm Purchase |
2020-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Linden Capital L.P. | 46,080 6.000% |
46,080 (New Position) |
Filing History |
| 2020-09-14 5:00 pm Purchase |
2020-09-01 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Ikarian Capital LLC | 108,127 16.400% |
108,127 (New Position) |
Filing History |
| 2020-08-31 9:40 pm Purchase |
2020-08-27 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Opaleye Management Inc. | 85,917 13.030% |
85,917 (New Position) |
Filing History |